Ashford Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.43M Sell
7,707
-485
-6% -$216K 0.4% 49
2025
Q1
$3.97M Buy
8,192
+273
+3% +$132K 0.51% 48
2024
Q4
$3.19M Hold
7,919
0.38% 51
2024
Q3
$3.68M Sell
7,919
-481
-6% -$224K 0.46% 49
2024
Q2
$3.94M Hold
8,400
0.53% 51
2024
Q1
$3.51M Sell
8,400
-956
-10% -$400K 0.48% 46
2023
Q4
$3.81M Buy
9,356
+3,299
+54% +$1.34M 0.51% 46
2023
Q3
$2.11M Sell
6,057
-420
-6% -$146K 0.31% 51
2023
Q2
$2.28M Sell
6,477
-106
-2% -$37.3K 0.32% 46
2023
Q1
$2.07M Buy
6,583
+7
+0.1% +$2.21K 0.31% 48
2022
Q4
$1.9M Sell
6,576
-167
-2% -$48.2K 0.29% 49
2022
Q3
$1.95M Sell
6,743
-2,462
-27% -$713K 0.3% 48
2022
Q2
$2.59M Sell
9,205
-8
-0.1% -$2.25K 0.37% 49
2022
Q1
$2.4M Sell
9,213
-544
-6% -$142K 0.26% 58
2021
Q4
$2.14M Buy
9,757
+1,568
+19% +$344K 0.21% 62
2021
Q3
$1.49M Buy
8,189
+1,183
+17% +$215K 0.13% 67
2021
Q2
$1.41M Sell
7,006
-420
-6% -$84.7K 0.13% 70
2021
Q1
$1.6M Buy
7,426
+1,717
+30% +$369K 0.15% 65
2020
Q4
$1.35M Buy
5,709
+219
+4% +$51.7K 0.13% 67
2020
Q3
$1.49M Sell
5,490
-361
-6% -$98.2K 0.18% 58
2020
Q2
$1.7M Buy
5,851
+863
+17% +$251K 0.22% 55
2020
Q1
$1.19M Buy
4,988
+228
+5% +$54.3K 0.21% 56
2019
Q4
$1.04M Buy
4,760
+2
+0% +$438 0.14% 61
2019
Q3
$806K Buy
4,758
+961
+25% +$163K 0.12% 69
2019
Q2
$696K Hold
3,797
0.09% 74
2019
Q1
$698K Sell
3,797
-383
-9% -$70.4K 0.1% 75
2018
Q4
$693K Hold
4,180
0.11% 75
2018
Q3
$806K Buy
+4,180
New +$806K 0.1% 74